Distinct subjects for predicate <http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/slot> sorted by frequency

ResourceCount
1-methylxanthine_has_metabolite_1-methyluric-acid1
14-hydroxyclarithromycin_maximum_concentration_continuous_value1
7-ethoxyresorufin_in_vitro_probe_substrate_of_enzyme_cyp1a21
7-hydroxyperphenazine_maximum_concentration_continuous_value1
9-hydroxyrisperidone_inhibition_constant_cyp2d61
9-hydroxyrisperidone_primary_total_clearance_mechanism_Renal_Excretion1
N-demethyldesacetyl-diltiazem_is_not_substrate_of_cyp2d61
N-demethyldesacetyl-diltiazem_substrate_of_cyp2d61
N-desalkylquetiapine_inhibits_cyp1a21
N-desalkylquetiapine_inhibits_cyp2c191
N-desalkylquetiapine_inhibits_cyp2c91
N-desalkylquetiapine_inhibits_cyp2d61
N-desalkylquetiapine_inhibits_cyp3a41
N-desalkylquetiapine_is_not_substrate_of_cyp3a41
N-desalkylquetiapine_substrate_of_cyp3a41
O-desmethylvenlafaxine_maximum_concentration_continuous_value1
R-citalopram_inhibits_cyp1a21
R-citalopram_inhibits_cyp2c191
R-citalopram_inhibits_cyp2c91
R-citalopram_inhibits_cyp2d61
R-citalopram_inhibits_cyp2e11
R-citalopram_inhibits_cyp3a41
R-citalopram_is_not_substrate_of_cyp2c191
R-citalopram_is_not_substrate_of_cyp2d61
R-citalopram_is_not_substrate_of_cyp3a41
R-citalopram_maximum_concentration_continuous_value1
R-citalopram_primary_total_clearance_mechanism_Renal_Excretion1
R-citalopram_substrate_of_cyp2c191
R-citalopram_substrate_of_cyp2d61
R-citalopram_substrate_of_cyp3a41
R-demethylcitalopram_inhibits_cyp1a21
R-demethylcitalopram_inhibits_cyp2c191
R-demethylcitalopram_inhibits_cyp2c91
R-demethylcitalopram_inhibits_cyp3a41
R-demethylcitalopram_is_not_substrate_of_cyp2c191
R-demethylcitalopram_is_not_substrate_of_cyp2d61
R-demethylcitalopram_maximum_concentration_continuous_value1
R-demethylcitalopram_substrate_of_cyp2c191
R-demethylcitalopram_substrate_of_cyp2d61
R-demethylcitalopram_substrate_of_cyp3a41
R-didemethylcitalopram_inhibits_cyp1a21
R-didemethylcitalopram_inhibits_cyp2d61
R-didemethylcitalopram_inhibits_cyp3a41
R-didemethylcitalopram_maximum_concentration_continuous_value1
R-warfarin_in_vitro_probe_substrate_of_enzyme_cyp1a21
R-warfarin_in_vitro_probe_substrate_of_enzyme_cyp3a41
S-demethylcitalopram_inhibits_cyp1a21
S-demethylcitalopram_inhibits_cyp2c191
S-demethylcitalopram_inhibits_cyp2c91
S-demethylcitalopram_inhibits_cyp3a41
S-demethylcitalopram_is_not_substrate_of_cyp2c191
S-demethylcitalopram_is_not_substrate_of_cyp2d61
S-demethylcitalopram_maximum_concentration_continuous_value1
S-demethylcitalopram_substrate_of_cyp2c191
S-demethylcitalopram_substrate_of_cyp2d61
S-demethylcitalopram_substrate_of_cyp3a41
S-didemethylcitalopram_inhibits_cyp1a21
S-didemethylcitalopram_inhibits_cyp2d61
S-didemethylcitalopram_inhibits_cyp3a41
S-didemethylcitalopram_maximum_concentration_continuous_value1
S-mephenytoin_in_vitro_probe_substrate_of_enzyme_cyp2c191
S-warfarin_in_vitro_probe_substrate_of_enzyme_cyp2c91
alosetron_increases_auc_fluoxetine1
alpha-naphthoflavone_in_vitro_selective_inhibitor_of_enzyme_cyp1a21
alprazolam_bioavailability_continuous_value1
alprazolam_has_metabolite_4-hydroxyalprazolam1
alprazolam_has_metabolite_alpha-hydroxyalprazolam1
alprazolam_increases_auc_nefazodone1
alprazolam_increases_auc_selegiline1
alprazolam_is_not_substrate_of_cyp1a21
alprazolam_is_not_substrate_of_cyp3a41
alprazolam_is_not_substrate_of_cyp3a51
alprazolam_maximum_concentration_continuous_value1
alprazolam_primary_metabolic_clearance_enzyme_cyp3a41
alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance1
alprazolam_substrate_of_cyp1a21
alprazolam_substrate_of_cyp3a41
alprazolam_substrate_of_cyp3a51
amiodarone_inhibits_cyp1a21
amiodarone_inhibits_cyp2c91
amiodarone_inhibits_cyp2d61
amiodarone_inhibits_cyp3a41
aripiprazole_bioavailability_continuous_value1
aripiprazole_has_metabolite_dehydro-aripiprazole1
aripiprazole_increases_auc_escitalopram1
aripiprazole_increases_auc_venlafaxine1
aripiprazole_inhibits_cyp1a21
aripiprazole_inhibits_cyp2c191
aripiprazole_inhibits_cyp2c91
aripiprazole_inhibits_cyp2d61
aripiprazole_inhibits_cyp3a41
aripiprazole_is_not_substrate_of_cyp1a11
aripiprazole_is_not_substrate_of_cyp1a21
aripiprazole_is_not_substrate_of_cyp2a61
aripiprazole_is_not_substrate_of_cyp2b61
aripiprazole_is_not_substrate_of_cyp2c191
aripiprazole_is_not_substrate_of_cyp2c81
aripiprazole_is_not_substrate_of_cyp2c91
aripiprazole_is_not_substrate_of_cyp2d61
aripiprazole_is_not_substrate_of_cyp2e11
aripiprazole_is_not_substrate_of_cyp3a41
aripiprazole_maximum_concentration_continuous_value1
aripiprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
aripiprazole_substrate_of_cyp1a11
aripiprazole_substrate_of_cyp1a21
aripiprazole_substrate_of_cyp2a61
aripiprazole_substrate_of_cyp2b61
aripiprazole_substrate_of_cyp2c191
aripiprazole_substrate_of_cyp2c81
aripiprazole_substrate_of_cyp2c91
aripiprazole_substrate_of_cyp2d61
aripiprazole_substrate_of_cyp2e11
aripiprazole_substrate_of_cyp3a41
asenapine_is_not_substrate_of_cyp2d61
asenapine_maximum_concentration_continuous_value1
asenapine_primary_total_clearance_mechanism_Metabolic_Clearance1
asenapine_substrate_of_cyp2d61
atazanavir_inhibits_cyp1a21
atazanavir_inhibits_cyp2a61
atazanavir_inhibits_cyp2b61
atazanavir_inhibits_cyp2c191
atazanavir_inhibits_cyp2c91
atazanavir_inhibits_cyp2d61
atazanavir_inhibits_cyp2e11
atazanavir_inhibits_cyp3a41
atazanavir_inhibits_cyp3a51
atomoxetine_bioavailability_continuous_value1
atomoxetine_has_metabolite_4-hydroxyatomoxetine1
atomoxetine_has_metabolite_N-desmethylatomoxetine1
atomoxetine_increases_auc_desipramine1
atomoxetine_inhibits_cyp1a21
atomoxetine_inhibits_cyp2c91
atomoxetine_inhibits_cyp2d61
atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
atorvastatin_bioavailability_continuous_value1
atorvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin1
atorvastatin_has_metabolite_para-hydroxy-atorvastatin1
atorvastatin_inhibition_constant_cyp2c81
atorvastatin_inhibits_cyp3a41
atorvastatin_is_not_substrate_of_cyp1a11
atorvastatin_is_not_substrate_of_cyp2b61
atorvastatin_is_not_substrate_of_cyp2c191
atorvastatin_is_not_substrate_of_cyp2c91
atorvastatin_is_not_substrate_of_cyp2d61
atorvastatin_is_not_substrate_of_cyp2e11
atorvastatin_is_not_substrate_of_cyp3a41
atorvastatin_is_not_substrate_of_cyp3a51
atorvastatin_maximum_concentration_continuous_value1
atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
atorvastatin_substrate_of_cyp1a11
atorvastatin_substrate_of_cyp2b61
atorvastatin_substrate_of_cyp2c191
atorvastatin_substrate_of_cyp2c91
atorvastatin_substrate_of_cyp2d61
atorvastatin_substrate_of_cyp2e11
atorvastatin_substrate_of_cyp3a41
atorvastatin_substrate_of_cyp3a51
beta-hydroxy-lovastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
beta-hydroxy-lovastatin_has_metabolite_6'-exomethylene-lovastatin1
beta-hydroxy-lovastatin_has_metabolite_6'beta-hydroxy-lovastatin1
beta-hydroxy-lovastatin_inhibition_constant_cyp2c81
beta-hydroxy-lovastatin_is_not_substrate_of_cyp3a41
beta-hydroxy-lovastatin_maximum_concentration_continuous_value1
beta-hydroxy-lovastatin_substrate_of_cyp3a41
beta-hydroxy-simvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
beta-hydroxy-simvastatin_has_metabolite_6'-exomethylene-simvastatin1
beta-hydroxy-simvastatin_has_metabolite_6'-hydroxy-simvastatin1
beta-hydroxy-simvastatin_has_metabolite_6'-hydroxymethyl-simvastatin1
beta-hydroxy-simvastatin_inhibition_constant_cyp2c81
beta-hydroxy-simvastatin_inhibits_cyp3a41
beta-hydroxy-simvastatin_is_not_substrate_of_cyp3a41
beta-hydroxy-simvastatin_substrate_of_cyp3a41
bufuralol_in_vitro_probe_substrate_of_enzyme_cyp2d61
bupropion_has_metabolite_erythrohydrobupropion1
bupropion_has_metabolite_hydroxybupropion1
bupropion_has_metabolite_threohydrobupropion1
bupropion_increases_auc_desipramine1
bupropion_inhibits_cyp2d61
bupropion_is_not_substrate_of_cyp2b61
bupropion_maximum_concentration_continuous_value1
bupropion_primary_total_clearance_mechanism_Metabolic_Clearance1
bupropion_primary_total_clearance_mechanism_Renal_Excretion1
bupropion_substrate_of_cyp2b61
celecoxib_inhibits_cyp2c191
celecoxib_inhibits_cyp2c91
celecoxib_inhibits_cyp2d61
celecoxib_inhibits_cyp3a41
celecoxib_is_not_substrate_of_cyp2c91
celecoxib_maximum_concentration_continuous_value1
celecoxib_primary_total_clearance_mechanism_Metabolic_Clearance1
celecoxib_substrate_of_cyp2c91
chlorpromazine_bioavailability_continuous_value1
chlorpromazine_inhibits_cyp2c191
chlorpromazine_maximum_concentration_continuous_value1
chlorzoxazone_in_vitro_probe_substrate_of_enzyme_cyp2e11
cimetidine_increases_auc_amitriptyline1
cimetidine_increases_auc_citalopram1
cimetidine_increases_auc_doxepin1
cimetidine_increases_auc_erythrohydrobupropion1
cimetidine_increases_auc_escitalopram1
cimetidine_increases_auc_imipramine1
cimetidine_increases_auc_mirtazapine1
cimetidine_increases_auc_nefazodone1
cimetidine_increases_auc_nortriptyline1
cimetidine_increases_auc_paroxetine1
cimetidine_increases_auc_quetiapine1
cimetidine_increases_auc_sertraline1
cimetidine_increases_auc_theophylline1
cimetidine_increases_auc_threohydrobupropion1
cimetidine_increases_auc_venlafaxine1
cimetidine_increases_auc_ziprasidone1
cimetidine_inhibits_cyp1a21
cimetidine_inhibits_cyp3a41
cimetidine_inhibits_cyp3a51
cinacalcet_has_metabolite_hydrocinnamic-acid1
cinacalcet_has_metabolite_hydroxy-hydrocinnamic-acid1
cinacalcet_inhibits_cyp1a21
cinacalcet_inhibits_cyp2c191
cinacalcet_inhibits_cyp2c91
cinacalcet_inhibits_cyp2d61
cinacalcet_inhibits_cyp3a41
cinacalcet_inhibits_cyp3a51
cinacalcet_is_not_substrate_of_cyp1a21
cinacalcet_is_not_substrate_of_cyp2d61
cinacalcet_is_not_substrate_of_cyp3a41
cinacalcet_primary_total_clearance_mechanism_Metabolic_Clearance1
cinacalcet_substrate_of_cyp1a21
cinacalcet_substrate_of_cyp2d61
cinacalcet_substrate_of_cyp3a41
ciprofloxacin_inhibits_cyp1a21
citalopram_bioavailability_continuous_value1
citalopram_has_metabolite_demethylcitalopram1
citalopram_has_metabolite_didemethylcitalopram1
citalopram_increases_auc_alprazolam1
citalopram_increases_auc_desipramine1
citalopram_increases_auc_selegiline1
citalopram_inhibits_cyp1a21
citalopram_inhibits_cyp2c191
citalopram_inhibits_cyp2c91
citalopram_inhibits_cyp2d61
citalopram_inhibits_cyp2e11
citalopram_inhibits_cyp3a41
citalopram_is_not_substrate_of_cyp2c191
citalopram_is_not_substrate_of_cyp3a41
citalopram_primary_total_clearance_mechanism_Metabolic_Clearance1
citalopram_primary_total_clearance_mechanism_Renal_Excretion1
citalopram_substrate_of_cyp2c191
citalopram_substrate_of_cyp2d61
citalopram_substrate_of_cyp3a41
clarithromycin_bioavailability_continuous_value1
clarithromycin_does_not_permanently_deactivate_catalytic_function_cyp3a41
clarithromycin_fraction_absorbed_continuous_value1
clarithromycin_has_metabolite_14-hydroxyclarithromycin1
clarithromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
clarithromycin_increases_auc_atorvastatin1
clarithromycin_increases_auc_lansoprazole1
clarithromycin_increases_auc_midazolam1
clarithromycin_increases_auc_pravastatin1
clarithromycin_increases_auc_trazodone1
clarithromycin_increases_auc_triazolam1
clarithromycin_inhibition_constant_cyp3a41
clarithromycin_inhibits_cyp3a41
clarithromycin_inhibits_cyp3a51
clarithromycin_is_not_substrate_of_cyp1a21
clarithromycin_is_not_substrate_of_cyp2c91
clarithromycin_is_not_substrate_of_cyp2d61
clarithromycin_is_not_substrate_of_cyp3a41
clarithromycin_maximum_concentration_continuous_value1
clarithromycin_substrate_of_cyp1a21
clarithromycin_substrate_of_cyp2c91
clarithromycin_substrate_of_cyp2d61
clarithromycin_substrate_of_cyp3a41
clopidogrel_increases_auc_bupropion1
clopidogrel_inhibition_constant_cyp2b61
clozapine-N-oxide_is_not_substrate_of_cyp2d61
clozapine-N-oxide_substrate_of_cyp2d61
clozapine_has_metabolite_7-hydroxyclozapine1
clozapine_has_metabolite_clozapine-N-oxide1
clozapine_has_metabolite_desmethylclozapine1
clozapine_inhibition_constant_cyp2c191
clozapine_inhibition_constant_cyp2c91
clozapine_inhibition_constant_cyp2d61
clozapine_inhibition_constant_cyp3a41
clozapine_inhibits_cyp2c191
clozapine_is_not_substrate_of_cyp1a21
clozapine_is_not_substrate_of_cyp2d61
clozapine_is_not_substrate_of_cyp3a41
clozapine_maximum_concentration_continuous_value1
clozapine_primary_total_clearance_mechanism_Metabolic_Clearance1
clozapine_substrate_of_cyp1a21
clozapine_substrate_of_cyp2d61
clozapine_substrate_of_cyp3a41
coumarin_in_vitro_probe_substrate_of_enzyme_cyp2a61
cyp1a1_controls_formation_of_threohydrobupropion1
cyp1a2_controls_formation_of_3-methylxanthine1
cyp1a2_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp1a2_controls_formation_of_N-dealkylperphenazine1
cyp1a2_controls_formation_of_O-desmethylvenlafaxine1
cyp1a2_controls_formation_of_hydroxybupropion1
cyp1a2_controls_formation_of_threohydrobupropion1
cyp1b1_controls_formation_of_threohydrobupropion1
cyp2a13_controls_formation_of_threohydrobupropion1
cyp2a6_controls_formation_of_threohydrobupropion1
cyp2b6_controls_formation_of_hydroxybupropion1
cyp2b6_controls_formation_of_threohydrobupropion1
cyp2c19_controls_formation_of_N-dealkylperphenazine1
cyp2c19_controls_formation_of_N-desmethylatomoxetine1
cyp2c19_controls_formation_of_N-desmethylsertraline1
cyp2c19_controls_formation_of_hydroxybupropion1
cyp2c19_controls_formation_of_threohydrobupropion1
cyp2c19_polymorphic_enzyme_True1
cyp2c8_controls_formation_of_6alpha-hydroxy-paclitaxel1
cyp2c8_controls_formation_of_N-dealkylperphenazine1
cyp2c8_controls_formation_of_threohydrobupropion1
cyp2c9_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp2c9_controls_formation_of_N-dealkylperphenazine1
cyp2c9_controls_formation_of_N-desmethylrosuvastatin1
cyp2c9_controls_formation_of_O-desmethylvenlafaxine1
cyp2c9_controls_formation_of_hydroxybupropion1
cyp2c9_controls_formation_of_threohydrobupropion1
cyp2c9_polymorphic_enzyme_True1
cyp2d6_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp2d6_controls_formation_of_4-hydroxyatomoxetine1
cyp2d6_controls_formation_of_4-hydroxydebrisoquine1
cyp2d6_controls_formation_of_9-hydroxyrisperidone1
cyp2d6_controls_formation_of_N-dealkylperphenazine1
cyp2d6_controls_formation_of_O-desmethylvenlafaxine1
cyp2d6_controls_formation_of_clozapine-N-oxide1
cyp2d6_controls_formation_of_desmethylclozapine1
cyp2d6_controls_formation_of_hydroxybupropion1
cyp2d6_controls_formation_of_threohydrobupropion1
cyp2d6_polymorphic_enzyme_True1
cyp2e1_controls_formation_of_1,3-dimethyluric-acid1
cyp2e1_controls_formation_of_N-dealkylperphenazine1
cyp2e1_controls_formation_of_threohydrobupropion1
cyp2j2_controls_formation_of_threohydrobupropion1
cyp3a4_controls_formation_of_1'-hydroxymidazolam1
cyp3a4_controls_formation_of_1,3-dimethyluric-acid1
cyp3a4_controls_formation_of_14-hydroxyclarithromycin1
cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp3a4_controls_formation_of_4-hydroxyalprazolam1
cyp3a4_controls_formation_of_4-hydroxymidazolam1
cyp3a4_controls_formation_of_6'beta-hydroxy-lovastatin1
cyp3a4_controls_formation_of_N-dealkylperphenazine1
cyp3a4_controls_formation_of_N-desmethyltamoxifen1
cyp3a4_controls_formation_of_N-desmethylvenlafaxine1
cyp3a4_controls_formation_of_alpha-hydroxyalprazolam1
cyp3a4_controls_formation_of_desmethylcitalopram1
cyp3a4_controls_formation_of_ortho-hydroxy-atorvastatin1
cyp3a4_controls_formation_of_para-hydroxy-atorvastatin1
cyp3a4_controls_formation_of_threohydrobupropion1
cyp3a4_controls_formation_of_ziprasidone-sulphoxide1
cyp3a4_polymorphic_enzyme_False1
cyp3a5_controls_formation_of_1'-hydroxymidazolam1
cyp3a5_controls_formation_of_4-hydroxyalprazolam1
cyp3a5_controls_formation_of_4-hydroxymidazolam1
cyp3a5_controls_formation_of_alpha-hydroxyalprazolam1
cyp3a5_controls_formation_of_ortho-hydroxy-atorvastatin1
cyp3a5_controls_formation_of_para-hydroxy-atorvastatin1
cyp3a5_controls_formation_of_threohydrobupropion1
cyp4a11_controls_formation_of_threohydrobupropion1
cyp4f1_controls_formation_of_threohydrobupropion1
debrisoquine_in_viVo_probe_substrate_of_enzyme_cyp2d61
debrisoquine_in_vitro_probe_substrate_of_enzyme_cyp2d61
dehydro-aripiprazole_inhibits_cyp1a21
dehydro-aripiprazole_is_not_substrate_of_cyp3a41
dehydro-aripiprazole_substrate_of_cyp3a41
demethylcitalopram_inhibits_cyp1a21
demethylcitalopram_inhibits_cyp2c191
demethylcitalopram_inhibits_cyp2c91
demethylcitalopram_inhibits_cyp3a41
demethylcitalopram_is_not_substrate_of_cyp2c191
demethylcitalopram_is_not_substrate_of_cyp3a41
demethylcitalopram_substrate_of_cyp2c191
demethylcitalopram_substrate_of_cyp2d61
demethylcitalopram_substrate_of_cyp3a41
desacetyldiltiazem_is_not_substrate_of_cyp2d61
desacetyldiltiazem_substrate_of_cyp2d61
desglymidodrine_primary_total_clearance_mechanism_Renal_Excretion1
desipramine_increases_auc_nefazodone1
desloratadine_increases_auc_fluoxetine1
desvenlafaxine_increases_auc_desipramine1
desvenlafaxine_is_not_substrate_of_cyp2d61
desvenlafaxine_substrate_of_cyp2d61
dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d61
dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d61
didemethylcitalopram_inhibits_cyp1a21
didemethylcitalopram_inhibits_cyp2d61
didemethylcitalopram_inhibits_cyp3a41
diltiazem_bioavailability_continuous_value1
diltiazem_has_metabolite_N-demethyldesacetyl-diltiazem1
diltiazem_has_metabolite_N-demethyldiltiazem1
diltiazem_has_metabolite_desacetyldiltiazem1
diltiazem_increases_auc_beta-hydroxy-lovastatin1
diltiazem_increases_auc_imipramine1
diltiazem_increases_auc_midazolam1
diltiazem_increases_auc_pravastatin1
diltiazem_increases_auc_simvastatin1
diltiazem_increases_auc_triazolam1
diltiazem_inhibition_constant_cyp3a41
diltiazem_inhibits_cyp3a41
diltiazem_is_not_substrate_of_cyp3a41
diltiazem_is_not_substrate_of_cyp3a51
diltiazem_maximum_concentration_continuous_value1
diltiazem_permanently_deactivates_catalytic_function_cyp3a41
diltiazem_primary_metabolic_clearance_enzyme_cyp2d61
diltiazem_primary_total_clearance_mechanism_Metabolic_Clearance1
diltiazem_substrate_of_cyp3a41
diltiazem_substrate_of_cyp3a51
diphenhydramine_increases_auc_venlafaxine1
duloxetine_increases_auc_theophylline1
duloxetine_inhibits_cyp2c191
duloxetine_inhibits_cyp2c91
duloxetine_inhibits_cyp2d61
duloxetine_inhibits_cyp3a41
duloxetine_inhibits_cyp3a51
duloxetine_is_not_substrate_of_cyp1a21
duloxetine_is_not_substrate_of_cyp2d61
duloxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
duloxetine_substrate_of_cyp1a21
duloxetine_substrate_of_cyp2d61
erythrohydrobupropion_maximum_concentration_continuous_value1
erythromycin_does_not_permanently_deactivate_catalytic_function_cyp3a41
erythromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
erythromycin_in_vitro_probe_substrate_of_enzyme_cyp3a41
erythromycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
erythromycin_increases_auc_alprazolam1
erythromycin_increases_auc_atorvastatin1
erythromycin_increases_auc_beta-hydroxy-simvastatin1
erythromycin_increases_auc_fluvastatin1
erythromycin_increases_auc_midazolam1
erythromycin_increases_auc_quetiapine1
erythromycin_increases_auc_risperidone1
erythromycin_increases_auc_rosuvastatin1
erythromycin_increases_auc_simvastatin1
erythromycin_increases_auc_triazolam1
erythromycin_inhibition_constant_cyp3a41
erythromycin_inhibits_cyp3a41
escitalopram_bioavailability_continuous_value1
escitalopram_has_metabolite_S-demethylcitalopram1
escitalopram_has_metabolite_S-didemethylcitalopram1
escitalopram_inhibits_cyp1a21
escitalopram_inhibits_cyp2c191
escitalopram_inhibits_cyp2c91
escitalopram_inhibits_cyp2d61
escitalopram_inhibits_cyp2e11
escitalopram_inhibits_cyp3a41
escitalopram_is_not_substrate_of_cyp2c191
escitalopram_is_not_substrate_of_cyp2d61
escitalopram_is_not_substrate_of_cyp3a41
escitalopram_maximum_concentration_continuous_value1
escitalopram_primary_total_clearance_mechanism_Metabolic_Clearance1
escitalopram_primary_total_clearance_mechanism_Renal_Excretion1
escitalopram_substrate_of_cyp2c191
escitalopram_substrate_of_cyp2d61
escitalopram_substrate_of_cyp3a41
eszopiclone_has_metabolite_S-N-desmethylzopiclone1
eszopiclone_has_metabolite_S-zopiclone-N-oxide1
eszopiclone_inhibits_CYP1A21
eszopiclone_inhibits_CYP2A61
eszopiclone_inhibits_CYP2C191
eszopiclone_inhibits_CYP2C91
eszopiclone_inhibits_CYP2D61
eszopiclone_inhibits_CYP2E11
eszopiclone_inhibits_CYP3A41
eszopiclone_is_not_substrate_of_cyp3a41
eszopiclone_primary_total_clearance_mechanism_Renal_Excretion1
eszopiclone_substrate_of_cyp2e11
eszopiclone_substrate_of_cyp3a41
fluconazole_bioavailability_continuous_value1
fluconazole_increases_auc_fluvastatin1
fluconazole_increases_auc_midazolam1
fluconazole_increases_auc_pravastatin1
fluconazole_increases_auc_rosuvastatin1
fluconazole_increases_auc_triazolam1
fluconazole_increases_auc_zolpidem1
fluconazole_inhibition_constant_cyp3a41
fluconazole_inhibits_cyp2c91
fluconazole_inhibits_cyp3a41
fluconazole_inhibits_cyp3a51
fluconazole_maximum_concentration_continuous_value1
fluconazole_primary_total_clearance_mechanism_Renal_Excretion1
fluoxetine_has_metabolite_norfluoxetine1
fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
fluoxetine_increases_auc_alprazolam1
fluoxetine_increases_auc_desipramine1
fluoxetine_increases_auc_imipramine1
fluoxetine_increases_auc_olanzapine1
fluoxetine_increases_auc_propafenone1
fluoxetine_inhibition_constant_cyp3a41
fluoxetine_inhibits_cyp2d61
fluoxetine_is_not_substrate_of_cyp2d61
fluoxetine_maximum_concentration_continuous_value1
fluoxetine_permanently_deactivates_catalytic_function_cyp2d61
fluoxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
fluoxetine_substrate_of_cyp2d61
fluphenazine_bioavailability_continuous_value1
fluphenazine_inhibition_constant_cyp1a21
fluphenazine_inhibition_constant_cyp2d61
Skipped 30 rows
fluvoxamine_primary_total_clearance_mechanism_Metabolic_Clearance1
fluvoxamine_substrate_of_cyp2d61
furafylline_in_vitro_selective_inhibitor_of_enzyme_cyp1a21
gemfibrozil_inhibits_cyp2c81
haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine1
haloperidol_has_metabolite_reduced-haloperidol1
haloperidol_increases_auc_quetiapine1
haloperidol_inhibition_constant_cyp2d61
haloperidol_inhibits_cyp2c191
haloperidol_is_not_substrate_of_cyp3a41
haloperidol_substrate_of_cyp3a41
hydroxybupropion_maximum_concentration_continuous_value1
hydroxybupropion_primary_total_clearance_mechanism_Renal_Excretion1
iloperidone_inhibits_cyp2d61
iloperidone_is_not_substrate_of_cyp1a11
iloperidone_is_not_substrate_of_cyp1a21
iloperidone_is_not_substrate_of_cyp2a61
iloperidone_is_not_substrate_of_cyp2b61
iloperidone_is_not_substrate_of_cyp2c191
iloperidone_is_not_substrate_of_cyp2c81
iloperidone_is_not_substrate_of_cyp2c91
iloperidone_is_not_substrate_of_cyp2d61
iloperidone_is_not_substrate_of_cyp2e11
iloperidone_is_not_substrate_of_cyp3a41
iloperidone_substrate_of_cyp1a11
iloperidone_substrate_of_cyp1a21
iloperidone_substrate_of_cyp2a61
iloperidone_substrate_of_cyp2b61
iloperidone_substrate_of_cyp2c191
iloperidone_substrate_of_cyp2c81
iloperidone_substrate_of_cyp2c91
iloperidone_substrate_of_cyp2d61
iloperidone_substrate_of_cyp2e11
iloperidone_substrate_of_cyp3a41
indinavir_increases_auc_venlafaxine1
indinavir_inhibits_cyp1a21
indinavir_inhibits_cyp2b61
indinavir_inhibits_cyp2c91
indinavir_inhibits_cyp2e11
indinavir_inhibits_cyp3a41
indinavir_inhibits_cyp3a51
indomethacin_bioavailability_continuous_value1
indomethacin_primary_total_clearance_mechanism_Metabolic_Clearance1
itraconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a51
itraconazole_increases_auc_3alpha-hydroxypravastatin1
itraconazole_increases_auc_alprazolam1
itraconazole_increases_auc_atorvastatin1
itraconazole_increases_auc_beta-hydroxy-lovastatin1
itraconazole_increases_auc_fluvastatin1
itraconazole_increases_auc_lovastatin1
itraconazole_increases_auc_midazolam1
itraconazole_increases_auc_pravastatin1
itraconazole_increases_auc_rosuvastatin1
itraconazole_increases_auc_selegiline1
itraconazole_increases_auc_triazolam1
itraconazole_increases_auc_zolpidem1
itraconazole_inhibition_constant_cyp3a41
itraconazole_inhibits_cyp3a41
itraconazole_sole_PK_effect_alter_metabolic_clearance_atorvastatin1
itraconazole_sole_PK_effect_alter_metabolic_clearance_beta-hydroxy-lovastatin1
itraconazole_sole_PK_effect_alter_metabolic_clearance_beta-hydroxy-simvastatin1
itraconazole_sole_PK_effect_alter_metabolic_clearance_lovastatin1
itraconazole_sole_PK_effect_alter_metabolic_clearance_simvastatin1
ketoconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
ketoconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
ketoconazole_increases_auc_O-desmethylvenlafaxine1
ketoconazole_increases_auc_alprazolam1
ketoconazole_increases_auc_amitriptyline1
ketoconazole_increases_auc_citalopram1
ketoconazole_increases_auc_desipramine1
ketoconazole_increases_auc_desvenlafaxine1
ketoconazole_increases_auc_imipramine1
ketoconazole_increases_auc_midazolam1
ketoconazole_increases_auc_simvastatin1
ketoconazole_increases_auc_triazolam1
ketoconazole_increases_auc_venlafaxine1
ketoconazole_increases_auc_zolpidem1
ketoconazole_inhibition_constant_cyp3a41
ketoconazole_inhibits_cyp3a41
ketoconazole_maximum_concentration_continuous_value1
ketoconazole_primary_total_clearance_mechanism_Metabolic_Clearance1
lansoprazole_bioavailability_continuous_value1
lansoprazole_increases_auc_lansoprazole1
lansoprazole_inhibits_cyp2d61
lansoprazole_inhibits_cyp3a41
lansoprazole_is_not_substrate_of_cyp2c191
lansoprazole_is_not_substrate_of_cyp3a41
lansoprazole_is_not_substrate_of_cyp3a51
lansoprazole_maximum_concentration_continuous_value1
lansoprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
lansoprazole_substrate_of_cyp2c191
lansoprazole_substrate_of_cyp3a41
lansoprazole_substrate_of_cyp3a51
leflunomide_has_metabolite_teriflunomide1
lithium_increases_auc_mirtazapine1
lithium_increases_auc_nefazodone1
lovastatin_bioavailability_continuous_value1
lovastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
lovastatin_first_pass_effect_continuous_value1
lovastatin_has_metabolite_beta-hydroxy-lovastatin1
lovastatin_inhibition_constant_cyp2c81
lovastatin_is_not_substrate_of_cyp3a41
lovastatin_maximum_concentration_continuous_value1
lovastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
lovastatin_substrate_of_cyp3a41
mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c191
metoprolol_in_viVo_probe_substrate_of_enzyme_cyp2d61
metronidazole_maximum_concentration_continuous_value1
metronidazole_primary_total_clearance_mechanism_Renal_Excretion1
mexiletine_inhibits_cyp1a21
midazolam_has_metabolite_1'-hydroxymidazolam1
midazolam_has_metabolite_4-hydroxymidazolam1
midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a41
midazolam_is_not_substrate_of_cyp3a51
midazolam_substrate_of_cyp3a51
midodrine_bioavailability_continuous_value1
midodrine_has_metabolite_desglymidodrine1
midodrine_primary_total_clearance_mechanism_Renal_Excretion1
mirtazapine_bioavailability_continuous_value1
mirtazapine_fraction_absorbed_continuous_value1
mirtazapine_increases_auc_paroxetine1
mirtazapine_inhibits_cyp1a21
mirtazapine_inhibits_cyp2c191
mirtazapine_inhibits_cyp2c91
mirtazapine_inhibits_cyp2d61
mirtazapine_inhibits_cyp2e11
mirtazapine_is_not_substrate_of_cyp1a21
mirtazapine_is_not_substrate_of_cyp2a61
mirtazapine_is_not_substrate_of_cyp2b61
mirtazapine_is_not_substrate_of_cyp2c191
mirtazapine_is_not_substrate_of_cyp2d61
mirtazapine_is_not_substrate_of_cyp2e11
mirtazapine_is_not_substrate_of_cyp3a41
mirtazapine_is_not_substrate_of_cyp3a51
mirtazapine_substrate_of_cyp1a21
mirtazapine_substrate_of_cyp2a61
mirtazapine_substrate_of_cyp2b61
mirtazapine_substrate_of_cyp2c191
mirtazapine_substrate_of_cyp2d61
mirtazapine_substrate_of_cyp2e11
mirtazapine_substrate_of_cyp3a41
mirtazapine_substrate_of_cyp3a51
modafinil-sulfone_inhibits_cyp2c191
modafinil_has_metabolite_modafinil-sulfone1
modafinil_inhibits_cyp2c191
modafinil_is_not_substrate_of_cyp3a41
modafinil_primary_total_clearance_mechanism_Metabolic_Clearance1
modafinil_substrate_of_cyp3a41
molindone_primary_total_clearance_mechanism_Metabolic_Clearance1
montelukast_inhibition_constant_cyp2c81
montelukast_inhibits_cyp1a21
montelukast_inhibits_cyp2a61
montelukast_inhibits_cyp2c191
montelukast_inhibits_cyp2c81
montelukast_inhibits_cyp2c91
montelukast_inhibits_cyp2d61
montelukast_inhibits_cyp3a41
nefazodone_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
nefazodone_increases_auc_alprazolam1
nefazodone_increases_auc_midazolam1
nefazodone_increases_auc_triazolam1
nefazodone_inhibits_cyp1a21
nefazodone_inhibits_cyp3a41
nefazodone_inhibits_cyp3a51
nefazodone_is_not_substrate_of_cyp1a21
nefazodone_is_not_substrate_of_cyp2c191
nefazodone_is_not_substrate_of_cyp2c81
nefazodone_is_not_substrate_of_cyp2c91
nefazodone_is_not_substrate_of_cyp2d61
nefazodone_is_not_substrate_of_cyp3a41
nefazodone_substrate_of_cyp1a21
nefazodone_substrate_of_cyp2c191
nefazodone_substrate_of_cyp2c81
nefazodone_substrate_of_cyp2c91
nefazodone_substrate_of_cyp2d61
nefazodone_substrate_of_cyp3a41
nicardipine_bioavailability_continuous_value1
norfloxacin_inhibits_cyp1a21
norfluoxetine_inhibition_constant_cyp3a41
olanzapine_has_metabolite_10-N-glucuronide1
olanzapine_increases_auc_selegiline1
olanzapine_inhibition_constant_cyp2c191
olanzapine_inhibition_constant_cyp2c91
olanzapine_inhibition_constant_cyp3a41
olanzapine_is_not_substrate_of_cyp2d61
olanzapine_maximum_concentration_continuous_value1
olanzapine_primary_total_clearance_mechanism_Metabolic_Clearance1
olanzapine_primary_total_clearance_mechanism_Renal_Excretion1
olanzapine_substrate_of_cyp2d61
omeprazole_in_vitro_probe_substrate_of_enzyme_cyp2c191
omeprazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c191
omeprazole_increases_auc_escitalopram1
omeprazole_inhibits_cyp2c191
omeprazole_inhibits_cyp2d61
p-nitrophenol_in_vitro_probe_substrate_of_enzyme_cyp2e11
paclitaxel_has_metabolite_6alpha-hydroxy-paclitaxel1
paclitaxel_in_vitro_probe_substrate_of_enzyme_cyp2c81
paliperidone_bioavailability_continuous_value1
paliperidone_inhibition_constant_cyp2d61
paliperidone_inhibits_cyp1a21
paliperidone_inhibits_cyp2a61
paliperidone_inhibits_cyp2c191
paliperidone_inhibits_cyp2c81
paliperidone_inhibits_cyp2c91
paliperidone_inhibits_cyp2d61
paliperidone_inhibits_cyp2e11
paliperidone_inhibits_cyp3a41
paliperidone_inhibits_cyp3a51
paliperidone_primary_total_clearance_mechanism_Renal_Excretion1
pantoprazole_bioavailability_continuous_value1
pantoprazole_inhibits_cyp2d61
pantoprazole_is_not_substrate_of_cyp2c191
pantoprazole_is_not_substrate_of_cyp3a41
pantoprazole_maximum_concentration_continuous_value1
pantoprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
pantoprazole_primary_total_clearance_mechanism_Renal_Excretion1
pantoprazole_substrate_of_cyp2c191
pantoprazole_substrate_of_cyp3a41
paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
paroxetine_in_vitro_selective_inhibitor_of_enzyme_cyp2d61
paroxetine_increases_auc_desipramine1
paroxetine_increases_auc_duloxetine1
paroxetine_increases_auc_imipramine1
paroxetine_increases_auc_mirtazapine1
paroxetine_increases_auc_nortriptyline1
paroxetine_increases_auc_paliperidone1
paroxetine_increases_auc_risperidone1
paroxetine_inhibits_cyp2d61
paroxetine_is_not_substrate_of_cyp2d61
paroxetine_permanently_deactivates_catalytic_function_cyp2d61
paroxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
paroxetine_substrate_of_cyp2d61
perphenazine_has_metabolite_7-hydroxyperphenazine1
perphenazine_inhibition_constant_cyp1a21
perphenazine_inhibition_constant_cyp2d61
perphenazine_inhibits_cyp2c191
perphenazine_is_not_substrate_of_cyp1a21
perphenazine_is_not_substrate_of_cyp2c191
perphenazine_is_not_substrate_of_cyp2d61
perphenazine_is_not_substrate_of_cyp3a41
perphenazine_maximum_concentration_continuous_value1
perphenazine_primary_total_clearance_mechanism_Metabolic_Clearance1
perphenazine_substrate_of_cyp1a21
perphenazine_substrate_of_cyp2c191
perphenazine_substrate_of_cyp2d61
perphenazine_substrate_of_cyp3a41
phenacetin_in_vitro_probe_substrate_of_enzyme_cyp1a21
pioglitazone_inhibition_constant_cyp2c81
prasugrel_increases_auc_bupropion1
pravastatin_has_metabolite_3alpha-hydroxypravastatin1
pravastatin_inhibits_cyp2c81
pravastatin_primary_total_clearance_mechanism_Renal_Excretion1
propafenone_inhibits_cyp1a21
propoxyphene_has_metabolite_norpropoxyphene1
quetiapine_has_metabolite_7-hydroxy-N-desalkyl-quetiapine1
quetiapine_has_metabolite_7-hydroxy-quetiapine1
quetiapine_has_metabolite_N-desalkylquetiapine1
quetiapine_has_metabolite_quetiapine-sulfoxide1
quetiapine_inhibits_cyp1a21
quetiapine_inhibits_cyp2c191
quetiapine_inhibits_cyp2c91
quetiapine_inhibits_cyp2d61
quetiapine_inhibits_cyp3a41
quetiapine_is_not_substrate_of_cyp1a21
quetiapine_is_not_substrate_of_cyp2c191
quetiapine_is_not_substrate_of_cyp2c91
quetiapine_is_not_substrate_of_cyp2e11
quetiapine_is_not_substrate_of_cyp3a41
quetiapine_primary_total_clearance_mechanism_Metabolic_Clearance1
quetiapine_substrate_of_cyp1a21
quetiapine_substrate_of_cyp2c191
quetiapine_substrate_of_cyp2c91
quetiapine_substrate_of_cyp2e11
quetiapine_substrate_of_cyp3a41
quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d61
quinidine_increases_auc_venlafaxine1
quinidine_inhibits_cyp2d61
quinidine_permanently_deactivates_catalytic_function_cyp2d61
rabeprazole_bioavailability_continuous_value1
rabeprazole_is_not_substrate_of_cyp2c191
rabeprazole_is_not_substrate_of_cyp3a41
rabeprazole_is_not_substrate_of_cyp3a51
rabeprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
rabeprazole_substrate_of_cyp2c191
rabeprazole_substrate_of_cyp3a41
rabeprazole_substrate_of_cyp3a51
ranolazine_inhibits_cyp2d61
ranolazine_inhibits_cyp3a41
ranolazine_inhibits_cyp3a51
ranolazine_is_not_substrate_of_cyp2d61
ranolazine_maximum_concentration_continuous_value1
ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance1
ranolazine_substrate_of_cyp2d61
reduced-haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine1
reduced-haloperidol_is_not_substrate_of_cyp3a41
reduced-haloperidol_substrate_of_cyp3a41
risperidone_bioavailability_continuous_value1
risperidone_has_metabolite_9-hydroxyrisperidone1
risperidone_increases_auc_erythromycin1
risperidone_increases_auc_quetiapine1
risperidone_increases_auc_selegiline1
risperidone_inhibition_constant_cyp2d61
risperidone_inhibits_cyp2c191
risperidone_is_not_substrate_of_cyp2d61
risperidone_is_not_substrate_of_cyp3a41
risperidone_maximum_concentration_continuous_value1
risperidone_primary_metabolic_clearance_enzyme_cyp2d61
risperidone_primary_total_clearance_mechanism_Metabolic_Clearance1
risperidone_substrate_of_cyp2d61
risperidone_substrate_of_cyp3a41
ritonavir_increases_auc_bupropion1
ritonavir_increases_auc_trazodone1
ritonavir_inhibits_cyp2d61
ritonavir_inhibits_cyp3a41
ritonavir_inhibits_cyp3a51
rosiglitazone_inhibition_constant_cyp2c81
rosiglitazone_inhibits_cyp1a11
rosiglitazone_inhibits_cyp1a21
rosiglitazone_inhibits_cyp2a61
rosiglitazone_inhibits_cyp2b61
rosiglitazone_inhibits_cyp2c191
rosiglitazone_inhibits_cyp2c81
rosiglitazone_inhibits_cyp2c91
rosiglitazone_inhibits_cyp2d61
rosiglitazone_inhibits_cyp2e11
rosiglitazone_inhibits_cyp3a41
rosiglitazone_inhibits_cyp3a51
rosuvastatin_bioavailability_continuous_value1
rosuvastatin_fraction_absorbed_continuous_value1
rosuvastatin_has_metabolite_N-desmethylrosuvastatin1
rosuvastatin_inhibits_cyp2c81
rosuvastatin_is_not_substrate_of_cyp3a41
rosuvastatin_maximum_concentration_continuous_value1
rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c91
rosuvastatin_primary_total_clearance_mechanism_Biliary_Excretion1
rosuvastatin_substrate_of_cyp3a41
sertraline_has_metabolite_N-desmethylsertraline1
sertraline_increases_auc_alprazolam1
sertraline_increases_auc_clozapine1
sertraline_increases_auc_clozapine-N-oxide1
sertraline_increases_auc_desipramine1
sertraline_increases_auc_desmethylclozapine1
sertraline_increases_auc_zolpidem1
sertraline_inhibits_cyp2d61
sertraline_is_not_substrate_of_cyp2c191
sertraline_substrate_of_cyp2c191
simvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
simvastatin_has_metabolite_beta-hydroxy-simvastatin1
simvastatin_inhibition_constant_cyp2c81
simvastatin_inhibits_cyp3a41
simvastatin_is_not_substrate_of_cyp3a41
simvastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
simvastatin_substrate_of_cyp3a41
sparteine_in_viVo_probe_substrate_of_enzyme_cyp2d61
sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c91
sulphaphenazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c91
tamoxifen_has_metabolite_4-hydroxytamoxifin1
tamoxifen_has_metabolite_N-desmethyltamoxifen1
tamoxifen_is_not_substrate_of_cyp2c91
tamoxifen_is_not_substrate_of_cyp2d61
tamoxifen_is_not_substrate_of_cyp3a41
tamoxifen_is_not_substrate_of_cyp3a51
tamoxifen_primary_total_clearance_mechanism_Metabolic_Clearance1
tamoxifen_substrate_of_cyp2c91
tamoxifen_substrate_of_cyp2d61
tamoxifen_substrate_of_cyp3a41
tamoxifen_substrate_of_cyp3a51
telithromycin_inhibits_cyp3a41
telithromycin_inhibits_cyp3a51
terbinafine_increases_auc_paroxetine1
terbinafine_increases_auc_venlafaxine1
terbinafine_inhibits_cyp2d61
teriflunomide_inhibits_cyp2c91
testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a41
theophylline_has_metabolite_1,3-dimethyluric-acid1
theophylline_has_metabolite_1-methylxanthine1
theophylline_has_metabolite_3-methylxanthine1
theophylline_has_metabolite_caffeine1
theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a21
theophylline_primary_total_clearance_mechanism_Metabolic_Clearance1
thioridazine_has_metabolite_mesoridazine1
thioridazine_has_metabolite_sulforidazine1
thioridazine_has_metabolite_thioridazine-5-sulfoxide1
thioridazine_inhibition_constant_cyp2d61
thioridazine_inhibits_cyp2c191
thioridazine_is_not_substrate_of_cyp2d61
thioridazine_substrate_of_cyp2d61
thiothixene_inhibition_constant_cyp2d61
thiothixene_inhibits_cyp2c191
threohydrobupropion_maximum_concentration_continuous_value1
threohydrobupropion_primary_total_clearance_mechanism_Renal_Excretion1
ticlopidine_increases_auc_bupropion1
ticlopidine_inhibition_constant_cyp2b61
ticlopidine_inhibition_constant_cyp2c191
tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c91
topiramate_inhibits_cyp1a21
topiramate_inhibits_cyp2a61
topiramate_inhibits_cyp2b61
topiramate_inhibits_cyp2c191
topiramate_inhibits_cyp2c91
topiramate_inhibits_cyp2d61
topiramate_inhibits_cyp2e11
topiramate_inhibits_cyp3a41
topiramate_inhibits_cyp3a51
topiramate_primary_total_clearance_mechanism_Renal_Excretion1
trazodone_bioavailability_continuous_value1
trazodone_has_metabolite_M-chlorophenylpiperazine1
trazodone_is_not_substrate_of_cyp3a41
trazodone_maximum_concentration_continuous_value1
trazodone_primary_total_clearance_mechanism_Renal_Excretion1
trazodone_substrate_of_cyp3a41
triazolam_in_vitro_probe_substrate_of_enzyme_cyp3a41
triazolam_increases_auc_nefazodone1
trimethoprim_inhibits_cyp2c81
troleandomycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
valproate_increases_auc_aripiprazole1
valproate_increases_auc_bupropion1
valproate_increases_auc_hydroxybupropion1
valproate_primary_total_clearance_mechanism_Metabolic_Clearance1
venlafaxine_fraction_absorbed_continuous_value1
venlafaxine_has_metabolite_N-desmethylvenlafaxine1
venlafaxine_has_metabolite_O-desmethylvenlafaxine1
venlafaxine_increases_auc_9-hydroxyrisperidone1
venlafaxine_increases_auc_alprazolam1
venlafaxine_increases_auc_desipramine1
venlafaxine_increases_auc_haloperidol1
venlafaxine_increases_auc_imipramine1
venlafaxine_increases_auc_risperidone1
venlafaxine_inhibits_cyp1a21
venlafaxine_inhibits_cyp2c91
venlafaxine_inhibits_cyp2d61
venlafaxine_inhibits_cyp3a41
venlafaxine_is_not_substrate_of_cyp2d61
venlafaxine_is_not_substrate_of_cyp3a41
venlafaxine_maximum_concentration_continuous_value1
venlafaxine_primary_total_clearance_mechanism_Metabolic_Clearance1
venlafaxine_substrate_of_cyp2d61
venlafaxine_substrate_of_cyp3a41
verapamil_increases_auc_imipramine1
verapamil_increases_auc_risperidone1
verapamil_inhibits_cyp1a21
verapamil_inhibits_cyp3a41
verapamil_inhibits_cyp3a51
voriconazole-N-oxide_inhibits_cyp2c191
voriconazole-N-oxide_inhibits_cyp2c91
voriconazole-N-oxide_inhibits_cyp3a41
voriconazole_bioavailability_continuous_value1
voriconazole_has_metabolite_voriconazole-N-oxide1
voriconazole_inhibits_cyp2c191
voriconazole_inhibits_cyp2c91
voriconazole_inhibits_cyp3a41
voriconazole_is_not_substrate_of_cyp2c191
voriconazole_is_not_substrate_of_cyp2c91
voriconazole_is_not_substrate_of_cyp3a41
voriconazole_maximum_concentration_continuous_value1
voriconazole_primary_total_clearance_mechanism_Metabolic_Clearance1
voriconazole_substrate_of_cyp2c191
voriconazole_substrate_of_cyp2c91
voriconazole_substrate_of_cyp3a41
zafirlukast_inhibits_cyp2c91
zafirlukast_inhibits_cyp3a41
zafirlukast_is_not_substrate_of_cyp2c91
zafirlukast_maximum_concentration_continuous_value1
zafirlukast_substrate_of_cyp2c91
zaleplon_bioavailability_continuous_value1
zaleplon_is_not_substrate_of_cyp2d61
zaleplon_is_not_substrate_of_cyp3a41
zaleplon_primary_total_clearance_mechanism_Metabolic_Clearance1
zaleplon_substrate_of_cyp2d61
zaleplon_substrate_of_cyp3a41
ziprasidone_has_metabolite_S-methyl-dihydroziprasidone1
ziprasidone_has_metabolite_benzisothiazole-sulphone1
ziprasidone_has_metabolite_benzisothiazole-sulphoxide1
ziprasidone_has_metabolite_ziprasidone-sulphoxide1
ziprasidone_inhibition_constant_cyp2d61
ziprasidone_inhibits_cyp1a21
ziprasidone_inhibits_cyp2c191
ziprasidone_inhibits_cyp2c91
ziprasidone_inhibits_cyp2d61
ziprasidone_inhibits_cyp3a41
ziprasidone_is_not_substrate_of_cyp1a21
ziprasidone_is_not_substrate_of_cyp2c191
ziprasidone_is_not_substrate_of_cyp2c91
ziprasidone_is_not_substrate_of_cyp2d61
ziprasidone_is_not_substrate_of_cyp3a41
ziprasidone_maximum_concentration_continuous_value1
ziprasidone_primary_total_clearance_mechanism_Metabolic_Clearance1
ziprasidone_substrate_of_cyp1a21
ziprasidone_substrate_of_cyp2c191
ziprasidone_substrate_of_cyp2c91
ziprasidone_substrate_of_cyp2d61
ziprasidone_substrate_of_cyp3a41
zolpidem_is_not_substrate_of_cyp3a41
zolpidem_is_not_substrate_of_cyp3a51
zolpidem_maximum_concentration_continuous_value1
zolpidem_substrate_of_cyp3a41
zolpidem_substrate_of_cyp3a51